back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-09-18 09:31 Tx date 2026-09-15 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,000
+300,000 vol $0.20 each |
375,000 | |
| Filed 2026-09-10 00:40 Tx date 2026-08-01 |
$LOBE
Lobe Sciences Ltd. |
Kideckel, David
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+3,000,000 vol |
3,000,000 | |
| Filed 2026-09-10 00:26 Tx date 2026-09-01 |
$LOBE
Lobe Sciences Ltd. |
Kideckel, David
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-09-02 12:42 Tx date 2026-09-01 |
$LOBE
Lobe Sciences Ltd. |
Kideckel, David
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-09-02 12:34 Tx date 2026-09-01 |
$LOBE
Lobe Sciences Ltd. |
Kideckel, David
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-08-31 08:45 Tx date 2026-08-11 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,000
+100,000 vol $0.10 each |
300,000 | |
| Filed 2026-08-13 07:55 Tx date 2026-08-11 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,000
+100,000 vol $0.10 each |
||
| Filed 2026-08-13 07:59 Tx date 2026-08-11 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$10,000
+50,000 vol $0.20 each |
250,000 | |
| Filed 2026-08-13 07:55 Tx date 2026-08-11 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,000
+100,000 vol $0.10 each |
300,000 | |
| Filed 2026-06-01 08:25 Tx date 2026-05-28 |
$KNE
Kane Biotech Inc. |
Kideckel, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+500,000 vol $0.05 each |
500,000 | |
| Filed 2026-06-01 08:19 Tx date 2025-06-25 |
$KNE
Kane Biotech Inc. |
Kideckel, David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-05-05 13:12 Tx date 2025-07-29 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$52,500
+75,000 vol $0.70 each |
75,000 | |
| Filed 2026-05-05 13:10 Tx date 2025-04-01 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-05-05 13:10 Tx date 2025-04-01 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-05-05 13:09 Tx date 2025-04-01 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-05-05 13:09 Tx date 2025-04-01 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-05-05 13:01 Tx date 2025-04-01 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-10-14 09:00 Tx date 2025-10-09 |
$PHRX
Pharmadrug Inc. |
Kideckel, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
+1,380,000 vol |
1,380,000 | |
| Filed 2025-06-20 19:00 Tx date 2025-06-06 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$10,000
+200,000 vol $0.05 each |
200,000 | |
| Filed 2025-06-10 11:52 Tx date 2025-06-06 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$20,000
+200,000 vol $0.10 each |